Neurotrack Awarded $3.3 Million Grant from National Institute on Aging to Study the Impact of its Cognitive Health Digital Therapeutic
Summary
"We are honored to receive the NIAs support to conduct this groundbreaking study into what could become a novel method for how we approach scalable risk reduction of pathological cognitive decline in the future," said Nick Bott, Psy.D., Chief Science Officer at Neurotrack. Evidence is growing, however, around the efficacy of multi-domain lifestyle interventions in reducing risk, delaying cognitive decline, and improving memory health. However, dissemination at a scale that can have population-level effects is limited by the intensity of the intervention, number and diversity of healthcare professionals engaged, cost, and participant inconvenience. The grant, awarded through the NIAs Small Business Innovation Research (SBIR) Seed Fund, will enable Neurotrack to fully evaluate its delivery, use, and impact on improving cognitive health among those at-risk over a two-year period. The impact it will have on communities around the world can be reduced, by making tools for cognitive health better accessible, alongside the pursuit of non-pharmacological interventions," said Elli Kaplan, Co-founder and CEO, Neurotrack.
Classifications
AskAI Classifications
LabelsLinked Companies
